Posts tagged Defective Drugs

• TWC Global LLC, Inc. Issues a Recall of Axcil and Desirin

  Jenny Albano | September 22, 2007 7:23 PM | 0 CommentsSacramento, CA Category: FDA & Prescription Drugs
  

  TWC Global LLC, Inc., in conjunction with the FDA, is recalling Axcil and Desirin products marked as dietary supplements because they include potentially dangerous unlabeled ingredients.FDA found the lot of 02B07 contains 3 mg/g of sildenafil, the active ingredient of a FDA-approved drug used for ED, as well as sulfosildenafil and sulfohomosildenafil, both are analogs of sildenafil. All of these...

• Bodee LLC, Inc. is Recalling Zencore Tabs Due to Undeclared Ingredients

  Jenny Albano | September 08, 2007 9:11 AM | 0 CommentsSacramento, CA Category: FDA & Prescription Drugs
  

  Bodee LLC, Inc., in conjunction with the FDA, announced they are recalling the dietary supplement Zencore Tabs because of undeclared ingredients.Representatives of the FDA found these undeclared ingredients during lab analysis and stated that the ingredients are potentially harmful to consumers.FDA asserts that its chemical analysis revealed that one lot of Zencore Tabs contains aminotadalafil,...

• Permax Recall

  Staff Writer | March 31, 2007 2:37 PM | 0 CommentsSacramento, CA Category: FDA & Prescription Drugs
  

  The FDA has requested the Parkinson's disease drug Permax to be pulled from the market after studies showed Permax has been linked to heart valve damage and increased risk of heart attack.At least 14 patients have needed to have heart valves replaced, but an FDA official says be believes that number to be higher. Patients are being told not to stop using the drug abruptly, and to consult with...

• Trasylol Increases a Patients Risk of Death

  Laura Mackie | February 19, 2007 12:31 PM | 0 CommentsSacramento, CA Category: FDA & Prescription Drugs
  

  According to a study recently published ( February 7, 2007) in the Journal of the American Medical Association, there is a significant increase in the possibility of death for patients taking the anti-bleeding drug known as aprotinin following cardiac surgery. Although aprotinin was approved by The Food and Drug Administration (FDA) in 1993, more recent advice by the agency has been to closely...

• Novel Drug therapies create new morbidity

  Ed Smith | October 23, 2006 4:07 PM | 0 CommentsSacramento, CA Category: FDA & Prescription Drugs
  

  During the recent Fourth INternational Conference on Inflammnatory bowel diseases, an Italian physician, Dr. Eduard Strange stated tha it is not surprising that this treatment [Remicade] is associated with side effects, including severe infections such as tuberculosis, and opportunistic infections including listeriosis, histoplasmosis, and many others (published as case reports or in the large...

• Ortho Evra and "confidentiality agreements" - We may never know how many have been injured.

  Ed Smith | October 18, 2006 5:23 PM | 0 CommentsSacramento, CA Category: FDA & Prescription Drugs
  

  In what may be viewed by some as a "disturbing" business practice, the maker of the Ortho Evra birth control patch appears to be 'settling Ortho Evra lawsuits almost as quickly as they are filed', in exchange for confidentiality agreements which prevent the persons settling from discussing the facts of their cases (and, in doing so, preventing the public from becoming better educated as to the...

• Bone Death in Women taking osteoporosis Drugs

  Ed Smith | October 18, 2006 5:16 PM | 0 CommentsSacramento, CA Category: FDA & Prescription Drugs
  

  It was recently reporter that there is a link between women taking certain bone strengthening drugs known as bisphosphonates, including ( Fosamax, Actonel, Boniva, Skelid, Didronel, Zometa, Aredia, and Bonefos) and death of bone tissue.The study was printed in the Harvard Women's Health Watch (September 2006).The above drugs are widely prescribed for osteoporosis and also to treat bone pain...